Author:
Herbst Roy S.,Wang Meina,Chen Lieping
Reference11 articles.
1. Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer;Chaft;J. Clin. Oncol.,2022
2. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat. Med.,2002
3. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial;Felip;Lancet (London, England),2021
4. Neoadjuvant Nivolumab Plus Chemotherapy in Resectable Lung Cancer;Forde;New England Journal of Medicine,2022
5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献